Safety, tolerability and efficacy of indacaterol, a novel once-daily beta(2)-agonist, in patients with COPD: a 28-day randomised, placebo controlled clinical trial. (Q51108291)
Jump to navigation
Jump to search
scientific article published on 30 September 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety, tolerability and efficacy of indacaterol, a novel once-daily beta(2)-agonist, in patients with COPD: a 28-day randomised, placebo controlled clinical trial. |
scientific article published on 30 September 2006 |
Statements
Safety, tolerability and efficacy of indacaterol, a novel once-daily beta(2)-agonist, in patients with COPD: a 28-day randomised, placebo controlled clinical trial. (English)
1 reference
Jutta Beier
1 reference
Pascal Chanez
1 reference
Jean-Benoit Martinot
1 reference
A J M Schreurs
1 reference
Ruzena Tkácová
1 reference
Weibin Bao
1 reference
Damon Jack
1 reference
Mark Higgins
1 reference
30 September 2006
1 reference
20
1 reference
6
1 reference
740-749
1 reference
Identifiers
1 reference